Fingerprint
Dive into the research topics of 'Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Nivolumab in patients with relapsed or refractory hematologic malignancy: Preliminary results of a phase ib study
Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma C. Scott, Ahmad Halwani, Martin Gutierrez, Michael M. Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Bradley Garelik
Research output: Contribution to journal › Article › peer-review
553
Scopus
citations